Birhanu A, Kebede M, Eshetu M, Shash E, Berhanu M, Ahmed E
Malar J. 2024; 23(1):291.
PMID: 39342297
PMC: 11439193.
DOI: 10.1186/s12936-024-05022-w.
Khan S, Alsulami M, Alsehimi A, Alzahrani M, Mosule D, Albohiri H
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204168
PMC: 11357596.
DOI: 10.3390/ph17081064.
Hadjilaou A, Brandi J, Riehn M, Friese M, Jacobs T
Nat Rev Neurol. 2023; 19(11):688-709.
PMID: 37857843
DOI: 10.1038/s41582-023-00881-4.
Akide Ndunge O, Shikani H, Dai M, Freeman B, Desruisseaux M
J Neurochem. 2023; 167(3):441-460.
PMID: 37814468
PMC: 10596299.
DOI: 10.1111/jnc.15972.
Akide Ndunge O, Kilian N, Salman M
Adv Sci (Weinh). 2022; 9(36):e2202944.
PMID: 36300890
PMC: 9798991.
DOI: 10.1002/advs.202202944.
Neurotransmitters and molecular chaperones interactions in cerebral malaria: Is there a missing link?.
Daniyan M, Fisusi F, Adeoye O
Front Mol Biosci. 2022; 9:965569.
PMID: 36090033
PMC: 9451049.
DOI: 10.3389/fmolb.2022.965569.
Cerebral malaria induced by : clinical features, pathogenesis, diagnosis, and treatment.
Song X, Wei W, Cheng W, Zhu H, Wang W, Dong H
Front Cell Infect Microbiol. 2022; 12:939532.
PMID: 35959375
PMC: 9359465.
DOI: 10.3389/fcimb.2022.939532.
Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections.
Bath P, Coleman C, Gordon A, Lim W, Webb A
F1000Res. 2022; 10:536.
PMID: 35685687
PMC: 9171293.
DOI: 10.12688/f1000research.51270.2.
The monoterpene 1,8-cineole prevents cerebral edema in a murine model of severe malaria.
Santos E, Silva L, Pinheiro A, Teixeira D, Peruchetti D, Silva-Aguiar R
PLoS One. 2022; 17(5):e0268347.
PMID: 35550638
PMC: 9098050.
DOI: 10.1371/journal.pone.0268347.
NADPH Oxidase: a Possible Therapeutic Target for Cognitive Impairment in Experimental Cerebral Malaria.
Kumar S, Prakash Babu P
Mol Neurobiol. 2021; 59(2):800-820.
PMID: 34782951
DOI: 10.1007/s12035-021-02598-1.
Efficacy and safety of dual intravenous artesunate plus quinine compared to intravenous artesunate for cerebral malaria in a triple blinded parallel multisite randomized controlled trial in Nigerian children: DUAL PAQ TRIAL Protocol.
Alao M, Orimadegun A, Ibrahim O, Oyenuga A, Asinobi A, Gbadero D
Trials. 2021; 22(1):721.
PMID: 34670598
PMC: 8527777.
DOI: 10.1186/s13063-021-05634-6.
Redox Biology of Infection and Consequent Disease.
Isaguliants M, Bartosch B, Ivanov A
Oxid Med Cell Longev. 2020; 2020:5829521.
PMID: 32089773
PMC: 7008258.
DOI: 10.1155/2020/5829521.
Monocyte-derived dendritic cells in malaria.
Hirako I, Assis P, Galvao-Filho B, Luster A, Antonelli L, Gazzinelli R
Curr Opin Microbiol. 2019; 52:139-150.
PMID: 31542508
PMC: 6981220.
DOI: 10.1016/j.mib.2019.08.002.
TRPV1 Contributes to Cerebral Malaria Severity and Mortality by Regulating Brain Inflammation.
Pereira D, Teixeira S, Murillo O, Peixoto E, Araujo M, Sousa N
Oxid Med Cell Longev. 2019; 2019:9451671.
PMID: 31223430
PMC: 6541938.
DOI: 10.1155/2019/9451671.
[Infections of the central nervous system by protozoa, helminths and fungi].
Deigendesch N, Schluter D, Siebert E, Stenzel W
Nervenarzt. 2019; 90(6):623-641.
PMID: 31073673
DOI: 10.1007/s00115-019-0719-1.
A retinal model of cerebral malaria.
Paquet-Durand F, Beck S, Das S, Huber G, Chang L, Schubert T
Sci Rep. 2019; 9(1):3470.
PMID: 30837488
PMC: 6401001.
DOI: 10.1038/s41598-019-39143-z.
Cerebral malaria is associated with differential cytoadherence to brain endothelial cells.
Storm J, Jespersen J, Seydel K, Szestak T, Mbewe M, Chisala N
EMBO Mol Med. 2019; 11(2).
PMID: 30610112
PMC: 6365927.
DOI: 10.15252/emmm.201809164.
Severe malaria and death risk factors among children under 5 years at Jason Sendwe Hospital in Democratic Republic of Congo.
Mutombo A, Mukuku O, Tshibanda K, Swana E, Mukomena E, Ngwej D
Pan Afr Med J. 2018; 29:184.
PMID: 30061962
PMC: 6061819.
DOI: 10.11604/pamj.2018.29.184.15235.
Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.
Lee N, Ha S, Sati P, Absinta M, Luciano N, Lefeuvre J
Brain. 2018; 141(6):1637-1649.
PMID: 29688408
PMC: 5972667.
DOI: 10.1093/brain/awy082.
Adjunctive therapy for severe malaria: a review and critical appraisal.
Varo R, Crowley V, Sitoe A, Madrid L, Serghides L, Kain K
Malar J. 2018; 17(1):47.
PMID: 29361945
PMC: 5781278.
DOI: 10.1186/s12936-018-2195-7.